|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ISRCTN |
|
Last refreshed on:
|
13 January 2015 |
|
Main ID: |
ISRCTN17184129 |
|
Date of registration:
|
26/09/2005 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Comparison of facility and home-based antiretroviral therapy delivery systems in Uganda
|
|
Scientific title:
|
Comparison of facility and home-based antiretroviral therapy delivery systems in Uganda: a randomised controlled trial |
|
Date of first enrolment:
|
15/02/2005 |
|
Target sample size:
|
1000 |
|
Recruitment status: |
Completed |
|
URL:
|
http://isrctn.com/ISRCTN17184129 |
|
Study type:
|
Interventional |
|
Study design:
|
Randomised controlled trial (Treatment)
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Uganda
| | | | | | | |
|
Contacts
|
|
Name:
|
|
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
Shabbar
Jaffar |
|
Address:
|
London School of Hygiene and Tropical Medicine (LSHTM)
Keppel Street
WC1E 7HT
London
United Kingdom |
|
Telephone:
|
+44 (0)20 7927 2418 |
|
Email:
|
shabbar.jaffar@lshtm.ac.uk |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: All HIV-infected adults (aged 18 years or more) who are started on antiretroviral therapy (ART) by a service provider (The acquired immunodeficiency syndrome [AIDS] Support Organisation) and who plan to remain in the study area for 12 months.
Exclusion criteria: 1. Already on ART and transferred from another centre
2. Live on islands and are difficult to follow-up
Age minimum:
Age maximum:
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)
Infections and Infestations
Human immunodeficiency virus
|
|
Intervention(s)
|
|
A comparison of two different ways of providing ART in an African setting - home-based versus facility-based HIV care
|
|
Primary Outcome(s)
|
|
Time to detectable viral load
|
|
Secondary Outcome(s)
|
1. Adherence
2. Cost effectiveness
3. Treatment failure
|
|
Source(s) of Monetary Support
|
|
Centers for Disease Control (CDC) (USA) - Co-operative Agreement (ref: IU01-PS000065-01), Medical Research Council (MRC) (UK)
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|